Risk Factor of COVID-19 Reinfection (Study on Patient at RSDC Wisma Atlet Kemayoran, Jakarta)

Lutfiani Fajrin(1Mail), Syahrizal Syarif(2),
(1) Department of Epidemiology, Faculty of Public Health, Universitas Indonesia, Indonesia
(2) Faculty of Public Health, Universitas Indonesia, Indonesia

Mail Corresponding Author

DOI : https://doi.org/10.30604/well.224412022

Full Text:    Language : en


Background: Reinfection of COVID-19 is defined as a person who has recovered from infection with COVID-19 and then re-infected. The number of reports of reinfection events in several countries shows the magnitude of the problem of reinfection. Demographic factors, behavior, and medical history are risk factors for reinfection. Objective: To analyze the relationship between age, gender, history of comorbidities, use of public transportation, visiting public places, and behavior of using masks with the incidence of COVID-19 reinfection. Methods: This research is an analytic study with a cross-sectional approach. The subjects of this study were patients with a history of reinfection who met the inclusion and exclusion criteria from the epidemiological surveillance data at the Wisma Atlet Hospital, Jakarta in July – December 2021. Results: The incidence of reinfection with age 20-29 years (p=0.001) with POR 2.70 (95%CI 2.11-3.48), using public transportation (p=0.001) POR 1.80 (95%CI 1.45-2.21), and traveling to public places (p=0.001) POR 2.88 (95%CI 2.11-3.93). Variables that were not significant were gender (p=0.259) POR 1.13 (95%CI 0.92-1.38) and comorbid burden (p=0.193) POR 0.81 (95%CI 0.59-1.09). Conclusion: Age, use of public transportation, and traveling to public places contributed to the incidence of reinfection by 2.4, 1.4, and 2.0 times, respectively.


COVID-19; reinfection; risk factor


Cavanaugh, A. M., Spicer, K. B., Thoroughman, D., Glick, C., & Winter, K. (2021). Reduced Risk of Reinfection with SARS-CoV-2 After COVID-19 Vaccination. Morbidity and Mortality Weekly Report, 70(32), 1081–1083.

CDC. (2020). Criteria for Investigating Suspected SARS-CoV-2 Reinfection. https://www.cdc.gov/coronavirus/2019-ncov/php/invest-criteria.html

CDC. (2021). Reinfection. https://www.cdc.gov/coronavirus/2019-ncov/your-health/reinfection.html

Cevik, M., Tate, M., Lloyd, O., Maraolo, A. E., Schafers, J., & Ho, A. (2021). SARS-CoV-2, SARS-CoV, and MERS-CoV viral load dynamics, duration of viral shedding, and infectiousness: a systematic review and meta-analysis. The Lancet Microbe, 2(1), e13–e22. https://doi.org/10.1016/S2666-5247(20)30172-5

Dan, J. M., & Et.al. (2021). Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection. Science, 371(6529). https://doi.org/10.1126/science.abf4063

Falahi, S., & Kenarkoohi, A. (2020). COVID-19 reinfection: prolonged shedding or true reinfection? New Microbes and New Infections, 38, 100812. https://doi.org/10.1016/j.nmni.2020.100812

Gallo Marin, B., Aghagoli, G., Lavine, K., Yang, L., Siff, E. J., Chiang, S. S., Salazar-Mather, T. P., Dumenco, L., Savaria, M. C., Aung, S. N., Flanigan, T., & Michelow, I. C. (2021). Predictors of COVID-19 severity: A literature review. Reviews in Medical Virology, 31(1), 1–10. https://doi.org/10.1002/rmv.2146

Gupta, V., Bhoyar, R. C., Jain, A., & Et.al. (2020). Asymptomatic Reinfection in 2 Healthcare Workers From India With Genetically Distinct Severe Acute Respiratory Syndrome Coronavirus 2. Clinical Infectious Disease, Xx Xxxx, 1–2. https://doi.org/10.1093/cid/ciaa1275

Hall, V. J., & Et.al. (2021). SARS-CoV-2 infection rates of antibody-positive compared with antibody-negative health-care workers in England: a large, multicentre, prospective cohort study (SIREN). The Lancet, 397(10283), 1459–1469. https://doi.org/10.1016/S0140-6736(21)00675-9

Hodcroft, E. B. (2020). Preliminary case report on the SARS-CoV-2 cluster in the UK, France, and Spain. Swiss Medical Weekly, 150(9–10), 1–8. https://doi.org/10.4414/smw.2020.20212

Hu, M., Lin, H., Wang, J., Xu, C., Tatem, A. J., Meng, B., Zhang, X., Liu, Y., Wang, P., Wu, G., Xie, H., & Lai, S. (2021). Risk of Coronavirus Disease 2019 Transmission in Train Passengers: An Epidemiological and Modeling Study. Clinical Infectious Diseases, 72(4), 604–610. https://doi.org/10.1093/cid/ciaa1057

Islam, M. Z., Riaz, B. K., Akbar Ashrafi, S. A., Farjana, S., Efa, S. S., & Khan, M. A. (2022). Severity of COVID-19 reinfection and associated risk factors: findings of a cross-sectional study in Bangladesh. MedRxiv, 2021.12.26.21268408. http://medrxiv.org/content/early/2022/01/01/2021.12.26.21268408.abstract

Iwasaki, A. (2021). What reinfections mean for COVID-19. The Lancet Infectious Diseases, 21(1), 3–5. https://doi.org/10.1016/S1473-3099(20)30783-0

Kai-wang, K., & Et.al, H. (2020). Coronavirus Disease 2019 ( COVID-19 ) Re-infection by a Phylogenetically Distinct Severe Acute Respiratory Syndrome Coronavirus 2 Strain Confirmed by Whole Genome Sequencing. Clinical Infectious Disease, 2019(Xx), 1–6. https://doi.org/10.1093/cid/ciaa1275

Kai-wang, K., & Hung., E. a. (2020). COVID-19 Re-infection by a Phylogenetically Distinct SARS-Coronavirus-2 Strain Confirmed by Whole Genome Sequencing. 1–25.

Kiva A. Fisher, E. a. (2020). Community and Close Contact Exposures Associated with COVID-19 Among Symptomatic Adults ≥18 Years in 11 Outpatient Health Care Facilities — United States, July 2020. MMWR. Morbidity and Mortality Weekly Report, 69(36), 1258–1264. https://doi.org/10.15585/mmwr.mm6936a5

Liu, S., Deng, R., Zhou, B., & Sun, J. (2021). Asymptomatic Reinfection in 2 Healthcare Workers From India With Genetically Distinct Severe Acute Respiratory Syndrome Coronavirus 2. Clinical Infectious Diseases, 73(9), E2821–E2823. https://doi.org/10.1093/cid/ciaa1503

Liu, T., Liang, W., & Et.al. (2020). Risk factors associated with COVID-19 infection: a retrospective cohort study based on contacts tracing. Emerging Microbes and Infections, 0(0), 1546–1553. https://doi.org/10.1080/22221751.2020.1787799

Liu, X., Liu, Q., & Et.al. (2020). Symptomatic Severe Acute Respiratory Syndrome Coronavirus 2 (SARS- CoV-2) Reinfection by a Phylogenetically Distinct Strain. Clinical Infectious Disease, March, 2020–2022. https://doi.org/10.1093/nsr/nwaa113

Maria Elena Flacco, E. a. (2022). Risk of SARS-CoV-2 reinfection 18 months after primary infection: population-level observational study. Paper Knowledge . Toward a Media History of Documents, 1–7.

Mensah, A. A., Lacy, J., & Et.al. (2020). Disease severity during SARS-COV-2 reinfection : a nationwide study. Journal of Infection, 84(January), 542–550.

Molina, L. P., Chow, S.-K., Nickel, A., & Love, J. E. (2020). Prolonged Detection of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) RNA in an Obstetric Patient With Antibody Seroconversion. Obstetrics and Gynecology, 136(4), 838–841. https://doi.org/10.1097/AOG.0000000000004086

NHTI. (2021). COVID-19 Signs and Symptoms, Reinfection, Variants and Vaccines.

Peltan, I. D., Beesley, S. J., Webb, B. J., Lopansri, B. K., Sinclair, W., Jacobs, J. R., & Brown, S. M. (2021). Evaluation of potential COVID-19 recurrence in patients with late repeat positive SARS-CoV-2 testing. PLoS ONE, 16(5 May), 1–14. https://doi.org/10.1371/journal.pone.0251214

Pung, R., Chiew, C. J., & Et.al. (2020). Investigation of three clusters of COVID-19 in Singapore: implications for surveillance and response measures. The Lancet, 395(10229), 1039–1046. https://doi.org/10.1016/S0140-6736(20)30528-6

Rothe, C., Schunk, M., Sothmann, P., & Et.al. (2020). Transmission of 2019-nCoV Infection from an Asymptomatic Contact in Germany. New England Journal of Medicine, 382(10), 970–971. https://doi.org/10.1056/nejmc2001468

Shen, Y., Li, C., & Et.al. (2020). Community Outbreak Investigation of SARS-CoV-2 Transmission among Bus Riders in Eastern China. JAMA Internal Medicine, 180(12), 1665–1671. https://doi.org/10.1001/jamainternmed.2020.5225

Shim, E., Tariq, A., Choi, W., Lee, Y., & Chowell, G. (2020). Transmission potential and severity of COVID-19 in South Korea. International Journal of Infectious Diseases, 93, 339–344. https://doi.org/10.1016/j.ijid.2020.03.031

Tillett, R. L., Sevinsky, J. R., & Et.al. (2020). Genomic Evidence for Reinfection with SARS-CoV-2: a Case Study. Lancet Infect, January.

Wölfl-Duchek, M., Bergmann, F., & Et.al. (2022). Sensitivity and Specificity of SARS-CoV-2 Rapid Antigen Detection Test Using Oral, Anterior Nasal, and Nasopharyngeal Swabs: a Diagnostic Accuracy Study. Microbiology Spectrum, 10(1), 1–9. https://doi.org/10.1128/spectrum.02029-21

Xiao, A. T., Tong, Y. X., & Zhang, S. (2020). Profile of RT-PCR for SARS-CoV-2: A Preliminary Study from 56 COVID-19 Patients. Clinical Infectious Diseases, 71(16), 2249–2251. https://doi.org/10.1093/cid/ciaa460

Article Metrics

 Abstract Views : 426 times
 Fulltext Downloaded : 94 times


  • There are currently no refbacks.

Creative Commons License
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.